Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/1958Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Fuller, John | - |
| dc.date.accessioned | 2021-03-19T03:28:40Z | - |
| dc.date.available | 2021-03-19T03:28:40Z | - |
| dc.date.issued | 2003-12 | - |
| dc.identifier.citation | The Lancet Volume 362, Issue 9399, 6 December 2003, Page 1937 | en_US |
| dc.identifier.issn | 0140-6736 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11434/1958 | - |
| dc.publisher | Elsevier | en_US |
| dc.subject | Europa Trial | en_US |
| dc.subject | Hope Srudy | en_US |
| dc.subject | Clinical Trials | en_US |
| dc.subject | Secondary Prevention | en_US |
| dc.subject | Cardiovascular Events | en_US |
| dc.subject | Myocardial Infarction | en_US |
| dc.subject | Ramipril | en_US |
| dc.subject | Perindopril | en_US |
| dc.subject | Cardiac Sciences Clinical Institute, Epworth HealthCare, Victoria, Australia | en_US |
| dc.title | Combine EUROPA and HOPE. | en_US |
| dc.type | Letter | en_US |
| dc.identifier.doi | https://doi.org/10.1016/S0140-6736(03)14976-8 | en_US |
| dc.identifier.journaltitle | The Lancet | en_US |
| dc.description.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/14667761/ | en_US |
| dc.type.contenttype | Text | en_US |
| Appears in Collections: | Cardiac Sciences | |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.